Search research articles
Contact Us
Filters
Showing results (1-10 of 141) with videos related to
Page
of 15
Sort By:
Molecules (Basel, Switzerland)
|
December 7, 2011
Tertiary alkylamines as nucleophiles in substitution reactions at heteroaromatic halide during the synthesis of the highly potent pirinixic acid derivative 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS-121)
Matthias Gabler, Manfred Schubert-Zsilavecz
Clinical Pharmacokinetics
|
April 28, 2006
Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients
Mario Wurglics, Manfred Schubert-Zsilavecz
Expert Opinion on Drug Discovery
|
April 12, 2013
Repairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator
Daniel Merk, Manfred Schubert-Zsilavecz
Clinical Pharmacokinetics
|
May 25, 2013
Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients
Christian Ude, Manfred Schubert-Zsilavecz, Mario Wurglics
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 26, 2006
Determination of St. John's wort flavonoid-metabolites in rat brain through high performance liquid chromatography coupled with fluorescence detection
Alexander Paulke, Manfred Schubert-Zsilavecz, Mario Wurglics
Future Medicinal Chemistry
|
June 2, 2012
Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators
Daniel Merk, Dieter Steinhilber, Manfred Schubert-Zsilavecz
Archiv Der Pharmazie
|
November 27, 2010
Functionalization of fatty acid mimetics for solid-phase coupling and subsequent target identification
Michaela Dittrich, Heiko Zettl, Manfred Schubert-Zsilavecz
Expert Opinion on Drug Discovery
|
November 23, 2013
Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator development
Daniel Merk, Dieter Steinhilber, Manfred Schubert-Zsilavecz
Expert Opinion on Therapeutic Patents
|
June 16, 2012
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present)
Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Current Topics in Medicinal Chemistry
|
November 13, 2014
Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonists
Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Page
of 15
Search research articles
Search
Showing results (1-10 of 141) with videos related to
Sort By:
Page
of 15
Molecules (Basel, Switzerland)
|
December 7, 2011
Tertiary alkylamines as nucleophiles in substitution reactions at heteroaromatic halide during the synthesis of the highly potent pirinixic acid derivative 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS-121)
Matthias Gabler, Manfred Schubert-Zsilavecz
Clinical Pharmacokinetics
|
April 28, 2006
Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients
Mario Wurglics, Manfred Schubert-Zsilavecz
Expert Opinion on Drug Discovery
|
April 12, 2013
Repairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator
Daniel Merk, Manfred Schubert-Zsilavecz
Clinical Pharmacokinetics
|
May 25, 2013
Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients
Christian Ude, Manfred Schubert-Zsilavecz, Mario Wurglics
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 26, 2006
Determination of St. John's wort flavonoid-metabolites in rat brain through high performance liquid chromatography coupled with fluorescence detection
Alexander Paulke, Manfred Schubert-Zsilavecz, Mario Wurglics
Future Medicinal Chemistry
|
June 2, 2012
Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators
Daniel Merk, Dieter Steinhilber, Manfred Schubert-Zsilavecz
Archiv Der Pharmazie
|
November 27, 2010
Functionalization of fatty acid mimetics for solid-phase coupling and subsequent target identification
Michaela Dittrich, Heiko Zettl, Manfred Schubert-Zsilavecz
Expert Opinion on Drug Discovery
|
November 23, 2013
Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator development
Daniel Merk, Dieter Steinhilber, Manfred Schubert-Zsilavecz
Expert Opinion on Therapeutic Patents
|
June 16, 2012
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present)
Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Current Topics in Medicinal Chemistry
|
November 13, 2014
Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonists
Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Page
of 15